Proposed Fundraise

Summary by AI BETAClose X

Renalytix plc announced a proposed fundraise of approximately £9.5 million gross proceeds at an issue price of 6 pence per share, representing a 44.6% premium to its recent closing price. This fundraise aims to support a new strategic collaboration and includes the conversion of outstanding Heights Capital debt of approximately US$4.69 million into equity. The company also reported preliminary unaudited revenues of approximately US$3 million for the twelve months ended June 30, 2026, and noted that its laboratory operations have been transferred to a new facility, increasing testing capacity by over 3.5 times and expected to yield cost savings of over US$2.6 million.

Disclaimer*

UK 100

Latest directors dealings